Sexual and reproductive health (SRH): a key issue in the emergency response to the coronavirus disease (COVID- 19) outbreak

Author:

Tang KunORCID,Gaoshan Junjian,Ahonsi Babatunde,Ali Moazzam,Bonet Mercedes,Broutet Nathalie,Kara Edna,Kim Caron,Thorson Anna,Thwin Soe Soe

Abstract

AbstractThe novel coronavirus disease (COVID-19) outbreak was first declared in China in December 2019, and WHO declared the pandemic on 11 March 2020. A fast-rising number of confirmed cases has been observed in all continents, with Europe at the epicentre of the outbreak at this moment.Sexual and reproductive health (SRH) and rights is a significant public health issue during the epidemics. The novel coronavirus (SARS-CoV-2) is new to humans, and only limited scientific evidence is available to identify the impact of the disease COVID-19 on SRH, including clinical presentation and outcomes of the infection during pregnancy, or for persons with STI/HIV-related immunosuppression. Beyond the clinical scope of SRH, we should not neglect the impacts at the health system level and disruptions or interruptions in regular provision of SRH services, such as pre- and postnatal checks, safe abortion, contraception, HIV/AIDS and sexually transmitted infections. Furthermore, other aspects merit attention such as the potential increase of gender-based violence and domestic abuse, and effects of stigma and discrimination associated with COVID-19 and their effects on SRH clients and health care providers. Therefore, there is an urgent need for the scientific community to generate sound clinical, epidemiological, and psycho-social behavioral links between COVID-19 and SRH and rights outcomes.

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynecology,Reproductive Medicine

Reference21 articles.

1. The World Health Organization. Coronavirus disease (COVID- 19) situation report as of 14th March, https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/. Accessed 15 Mar 2020.

2. The United Nations Population Fund Asia and Pacific Regional Office. Coronavirus Guidance Document. https://china.unfpa.org/en/publications/200206001 2020.

3. The World Health Organization. 2019 Novel Coronavirus Global Research and Innovation Forum: Towards a Research Roadmap. https://www.who.int/blueprint/priority-diseases/key-action/Overview_of_SoA_and_outline_key_knowledge_gaps.pdf?ua=1.

4. WHO. COVID-19: Operational guidance for maintaining essential health services during an outbreak. Interim guidance: 25 March 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/maintaining-essential-health-services-and-systems.

5. Neonates tested SARS-CoV-2 positive 30 hours after birth. CNR.cn. http://www.cnr.cn/hubei/yuanchuang/20200205/t20200205_524961963.shtml. Accessed 18 Feb 2020.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3